Results 171 to 180 of about 4,251 (181)

Acalabrutinib/obinutuzumab

Reactions Weekly, 2021
openaire   +1 more source

Cardiotoxicity in patients treated with acalabrutinib

Blood, 2022
openaire   +2 more sources

Novel Bruton tyrosine kinase inhibitor acalabrutinib quantification by validated LC-MS/MS method: An application to pharmacokinetic study in Sprague Dawley rats

Journal of Pharmaceutical and Biomedical Analysis, 2019
David Paul, N Satheeshkumar
exaly  

A Manufacturing Process to an Intermediate in the Synthesis of Acalabrutinib

Organic Process Research and Development, 2018
Michael Golden
exaly  

Acalabrutinib/Ibrutinib

Reactions Weekly
  +4 more sources

Time to Next Treatment in Patients with Chronic Lymphocytic Leukemia Initiating First-Line Ibrutinib or Acalabrutinib

Future Oncology
Marie-Helene Lafeuille, Moshe Yair Levy
exaly  

Acalabrutinib/zanubrutinib

Reactions Weekly
openaire   +1 more source

Acalabrutinib/pentoxifylline

Reactions Weekly
openaire   +1 more source

Acalabrutinib/prednisone

Reactions Weekly
openaire   +1 more source

Acalabrutinib/obinutuzumab

Reactions Weekly
openaire   +1 more source